C12Y 208/03016
Formyl-coa transferase
Official title: Formyl-CoA transferase (2.8.3.16)
C12Y208/03016 (Formyl-coa transferase) appears on 6 US grants and 10 published applications in this corpus.
Search patents in C12Y- Granted patents
- 6
- Published applications
- 10
- Assignees
- 7
- Inventors
- 28
- Latest grant
- 23 Sep 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2004 | 0 | 2 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 1 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 1 | 0 |
| 2014 | 1 | 1 |
| 2015 | 0 | 1 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 1 | 0 |
| 2019 | 1 | 1 |
| 2020 | 1 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 1 |
| 2023 | 0 | 2 |
| 2024 | 0 | 1 |
| 2025 | 1 | 0 |
By publication year.
Recent patents
- Methods and compositions for treating hyperoxaluria23 Sep 2025US 12,421,518 B2Tenza, Inc.
- Compositions and methods for treating or preventing oxalate-related disease19 May 2020US 10,653,726 B2Oxthera Intellectual Property AB
- Compositions and methods for oxalate reduction30 Apr 2019US 10,272,043 B2Oxthera Intellectual Property AB
- Compositions and methods for treating or preventing oxalate-related disease11 Dec 2018US 10,149,866 B2Oxthera Intellectual Property AB
- Compositions and methods for oxalate reduction2 Dec 2014US 8,900,575 B2Oxthera Intellectual Property AB
- Bacteria engineered to treat disorders in which oxalate is detrimental20 Jun 2024US 2024/0197843 A1Synlogic Operating Company, Inc.
- Microbial consortia1 Jun 2023US 2023/0165913 A1Federation Bio, Inc.
- Bacteria engineered to treat disorders in which oxalate is detrimental23 Mar 2023US 2023/0092431 A1Synlogic Operating Company, Inc.
- Methods and compositions for treating hyperoxaluria20 Jan 2022US 2022/0017909 A1Novome Biotechnologies, Inc.
- Compositions and methods for treating or preventing oxalate-related disease28 Mar 2019US 2019/0091268 A1Oxthera Intellectual Property AB
Most cited
By later US patents
- Compositions and methods for treating or preventing oxalate-related disease19US 8,486,389 B2Oxthera, Inc. · 2013
- Compositions and methods for oxalate reduction5US 8,900,575 B2Oxthera Intellectual Property AB · 2014
- Compositions and methods for treating or preventing oxalate-related disease4US 10,149,866 B2Oxthera Intellectual Property AB · 2018
- Compositions and methods for treating or preventing oxalate-related disease1US 10,653,726 B2Oxthera Intellectual Property AB · 2020